Processa Pharmaceuticals ... (PCSA)
NASDAQ: PCSA
· Real-Time Price · USD
0.33
0.03 (9.78%)
At close: Jun 09, 2025, 3:59 PM
Processa Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 175.4K | 175.4K | 175.4K | 175.4K | -277.95K | -277.95K | -277.95K |
Cost of Revenue | 3.42M | 6.23M | 6.23M | 4.98M | 7.69M | 8.99M | 9.2M | 13.09M | 10.6M | 9.72M | 9.72M | 6.78M | 10.02M | 8.98M | 9.04M | 5.93M | 2.47M |
Gross Profit | -3.42M | -6.23M | -6.23M | -4.98M | -7.69M | -8.99M | -9.2M | -13.09M | -10.6M | -9.72M | -9.55M | -6.6M | -9.84M | -8.81M | -9.32M | -6.21M | -2.75M |
Operating Income | -9.24M | -14.86M | -14.6M | -13.34M | -12.97M | -11.46M | -7.52M | -11.41M | -13.87M | -12.99M | -17.83M | -14.88M | -13.17M | -12.13M | -19.16M | -19M | -16.34M |
Interest Income | 46.17K | 129.39K | 187.89K | 233.4K | 335.4K | 335.64K | 326.65K | 277.7K | 183.08K | 101.2K | 49.13K | 14.2K | 8.63K | 11.99K | 10.84K | 9.08K | 7.29K |
Pretax Income | -11.96M | -11.85M | -11.53M | -10.22M | -9.83M | -11.12M | -21.73M | -25.67M | -28.22M | -27.42M | -17.78M | -14.87M | -13M | -11.96M | -19.04M | -19.07M | -16.6M |
Net Income | -11.96M | -11.85M | -11.53M | -10.22M | -9.83M | -6.93M | -38.94M | -42.85M | -45.4M | -48.79M | -17.56M | -14.56M | -12.55M | -11.43M | -17.98M | -18.06M | -15.64M |
Selling & General & Admin | 4.77M | 4.78M | 4.91M | 4.79M | 4.46M | 5.67M | 7.15M | 9.05M | 10.06M | 8.76M | 7.44M | 5.86M | 5.15M | 4.68M | 5.37M | 4.45M | 3.5M |
Research & Development | 7.32M | 7.27M | 6.88M | 5.74M | 5.7M | 5.79M | 7.64M | 9.63M | 11.08M | 11.49M | 10.39M | 8.97M | 7.45M | 6.88M | 6.52M | 5.33M | 4.15M |
Other Expenses | 71.7K | 71.7K | -113.66K | -113.66K | -83.46K | n/a | 185.36K | 185.36K | 83.46K | n/a | n/a | n/a | n/a | n/a | n/a | 2M | 2M |
Operating Expenses | 12.09M | 12.05M | 11.79M | 10.53M | 10.16M | 11.46M | 14.79M | 18.68M | 21.13M | 20.26M | 17.83M | 14.83M | 12.6M | 11.57M | 11.89M | 9.79M | 7.64M |
Interest Expense | n/a | n/a | 4.19M | 4.19M | 4.19M | 4.19M | 8.34M | 8.37M | 8.37M | 8.37M | 41.76K | 6.82K | 8.63K | 7.41K | 62.41K | 246.85K | 264.31K |
Selling & Marketing Expenses | -139 | -139 | -279 | -279 | -140 | -140 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 9.24M | 14.86M | 14.6M | 13.34M | 12.97M | 11.46M | 14.79M | 18.68M | 21.13M | 20.26M | 17.83M | 14.83M | 12.6M | 11.57M | 11.89M | 9.79M | 7.64M |
Income Tax Expense | n/a | -139 | 2.04M | 4.21M | 4.19M | n/a | 19.36M | 17.16M | 17.19M | 21.37M | -212.66K | -298.4K | -442.95K | -530.61K | -1.06M | -1.01M | -962.14K |
Shares Outstanding (Basic) | 9.53M | 3.7M | 3.28M | 2.98M | 2.47M | 1.89M | 1.35M | 1.35M | 1.14M | 823.11K | 810.01K | 797.02K | 791.55K | 787.3K | 776.57K | 770.32K | 729.18K |
Shares Outstanding (Diluted) | 9.53M | 3.7M | 3.28M | 2.98M | 2.47M | 1.89M | 1.35M | 1.35M | 1.14M | 823.11K | 810.01K | 797.02K | 791.55K | 787.3K | 776.57K | 770.32K | 729.18K |
EPS (Basic) | -3.17 | -3.97 | -4.44 | -4.91 | -5.8 | -4.55 | -45.05 | -50.95 | -55.45 | -59.6 | -21.8 | -18.2 | -15.8 | -14.6 | -24.4 | -31.6 | -30.2 |
EPS (Diluted) | -3.17 | -3.97 | -4.44 | -4.91 | -5.8 | -4.55 | -45.05 | -50.95 | -55.45 | -59.6 | -21.8 | -18.2 | -15.8 | -14.6 | -24.4 | -31.6 | -30.2 |
EBITDA | -9.24M | -12.05M | -11.79M | -10.53M | -10.04M | -11.23M | -14.36M | -18.06M | -20.44M | -19.47M | -17.03M | -14.07M | -12.17M | -11.1M | -18.11M | -17.97M | -15.5M |
EBIT | -9.24M | -12.05M | -11.79M | -10.53M | -10.16M | -11.46M | -14.79M | -18.68M | -21.13M | -20.26M | -17.82M | -14.83M | -12.95M | -11.91M | -18.93M | -18.83M | -16.34M |
Depreciation & Amortization | 643.00 | 782.00 | 621.00 | 500.00 | 20.54K | 40.2K | 256.58K | 474.46K | 674.13K | 874.01K | 876.37K | 875.42K | 875.27K | 875.35K | 857.42K | 841.36K | 822.6K |